News
Discover the latest news stories, blog posts and publications from Cobra's expert team
Posts about
Advanced Therapy Medicinal Product
Cobra Biologics and Symbiosis Awarded £1.9m ($2.5m USD) Innovate UK Grant
Funding will be used to develop world-leading capabilities in drug substance and drug product viral vector production for gene and immunotherapy
Cobra Biologics, an international contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, and Symbiosis Pharmaceutical Services, a contract manufacturing organisation (CMO) specialising in sterile Fill Finish, today announced that they have been awarded a 16-month collaborative grant of £1.9m from Innovate UK.
Cobra Biologics Awarded £2.6m ($3.4m USD) from Innovate UK
Capital infrastructure investment to embed and secure clinical and commercial viral vector manufacturing capability within the UK
Capital infrastructure investment to embed and secure clinical and commercial viral vector manufacturing capability within the UK Award made as part of UK’s Innovation Agency’s Industrial Strategy boost for UK medicines with £70m of funding to help develop new treatments Cobra Biologics, an international CDMO of biologics and pharmaceuticals, announced that it has been awarded £2.6 million ($3.4 million) capital infrastructure investment by